Pacira BioSciences (PCRX)
(Delayed Data from NSDQ)
$15.30 USD
+0.25 (1.66%)
Updated Oct 1, 2024 04:00 PM ET
Pre-Market: $15.25 -0.05 (-0.33%) 8:56 AM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Earnings News For PCRX
-
Pacira (PCRX) Down 27.9% Since Last Earnings Report: Can It Rebound?
-
Pacira (PCRX) Q2 Earnings Beat, Exparel Sales Drive Revenues
-
Pacira: Q2 Earnings Snapshot
-
Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates
-
Pacira BioSciences Reports Second Quarter 2024 Financial Results
-
Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?
-
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
-
Pacira: Q1 Earnings Snapshot
-
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program
-
Pacira (PCRX) Q4 Earnings Match, Exparel Sales Drive Revenues
-
Pacira: Q4 Earnings Snapshot
-
Pacira (PCRX) Matches Q4 Earnings Estimates
-
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Pacira (PCRX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
-
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
-
Pacira (PCRX) Q3 Earnings and Revenues Miss, '23 View Updated
-
Pacira (PCRX) Misses Q3 Earnings and Revenue Estimates
-
Pacira: Q3 Earnings Snapshot
-
Pacira BioSciences Reports Third Quarter 2023 Financial Results
-
Pacira (PCRX) to Report Q3 Results: Wall Street Expects Earnings Growth
-
Pacira (PCRX) Down 8.9% Since Last Earnings Report: Can It Rebound?
-
Pacira (PCRX) Q2 Earnings and Sales Miss, '23 View Updated
-
Pacira (PCRX) Lags Q2 Earnings and Revenue Estimates
-
Pacira: Q2 Earnings Snapshot
-
Pacira BioSciences Reports Second Quarter 2023 Financial Results